Suchergebnisse - "López-Medina, Eduardo"

PubPharm (4)

1

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults : a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Dayan, G. | Rouphael, N. | Walsh, S. | +120

2

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019 : a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

enthalten in: Lancet (London, England) | 2022

von Bravo, L. | Smolenov, I. | Han, H. | +44

CommentIn: Lancet. 2022 Jan 29;399(10323):415-417. - PMID 35065704

3

Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years : a randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2020

von Biswal, S. | Borja-Tabora, C. | Martinez Vargas, L. | +67

CommentIn: Lancet. 2020 May 2;395(10234):1402-1404. - PMID 32197106

4

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

enthalten in: The New England journal of medicine | 2019

von Biswal, S. | Reynales, H. | Saez-Llorens, X. | +39

CommentIn: N Engl J Med. 2020 Apr 30;382(18):1769. - PMID 32348658

1
[1]